STIFEL FINANCIAL CORP - ARMATA PHARMACEUTICALS INC ownership

ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 24 filers reported holding ARMATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of ARMATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$59,000
-6.3%
19,7290.0%0.00%
Q3 2020$63,000
-18.2%
19,7290.0%0.00%
Q2 2020$77,000
+10.0%
19,729
-12.7%
0.00%
Q1 2020$70,000
-4.1%
22,5990.0%0.00%
Q4 2019$73,000
-13.1%
22,5990.0%0.00%
Q3 2019$84,00022,5990.00%
Other shareholders
ARMATA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,382$481,1460.01%
SeaCrest Wealth Management, LLC 18,130$54,3900.01%
Edgewood Management 100,000$300,0000.00%
Trifecta Capital Advisors, LLC 714$2,1420.00%
Tower Research Capital LLC (TRC) 5,577$16,7310.00%
ROYAL BANK OF CANADA 18$00.00%
VANGUARD GROUP INC 90,969$272,9070.00%
UBS Group AG 2,249$6,7470.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 571$1,7130.00%
DIMENSIONAL FUND ADVISORS LP 11,472$34,4160.00%
View complete list of ARMATA PHARMACEUTICALS INC shareholders